MARKET WIRE NEWS

Neuraxis Inc. (NYSE : NRXS ) Stock

MWN-AI** Summary

MWN-AI** Analysis

**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.


Description


NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.


Quote


Last:$7.25
Change Percent: 0.28%
Open:$7.02
Close:$7.23
High:$7.35
Low:$6.75
Volume:44,032
Last Trade Date Time:04/02/2026 04:00:00 pm

Stock Data


Market Cap:$49,215,991
Float:9,161,418
Insiders Ownership:3.23%
Institutions:8
Short Percent:N/A
Industry:Medical Equipment & Supplies
Sector:Healthcare
Website:https://www.neuraxis.com
Country:US
City:Carmel

Recent News Releases


Subscribe to Our Newsletter


Message Board Posts


**MWN-AI FAQ is based on asking OpenAI questions about Neuraxis Inc. (NYSE: NRXS).

Link Market Wire News to Your X Account

Download The Market Wire News App